Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-20

Clinical Trial Update: Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin

View source ↗

Summary

A clinical trial update examining oxidative stress markers in early miscarriage, including ischemia of modified albumin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital | Conditions: First Trimester Pregnancy, Fetal Heart Activity Absent | Status: UNKNOWN